(b)
the sponsor, investigators, potential subjects, subjects, and clinical trial sites;
← art_25__para_1__point_a__text_1 · All articles · art_25__para_1__point_b__text_1 →
Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.